ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
162 hedge funds and large institutions have $873M invested in Achillion Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 44 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $852M → $873M (+$20.3M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
162
Holding in Top 10
3
Calls
$13M
Puts
$4.38M
Top Buyers
| 1 | +$12.3M | |
| 2 | +$11.5M | |
| 3 | +$7.53M | |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
+$7.5M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$7.24M |
Top Sellers
| 1 | -$35.7M | |
| 2 | -$25.6M | |
| 3 | -$15.7M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$15.1M |
| 5 |
JPMorgan Chase & Co
New York
|
-$4.9M |